News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15,780 Results
Type
Article (2366)
Company Profile (7)
Press Release (13407)
Section
Business (6310)
Career Advice (87)
Deals (926)
Drug Delivery (11)
Drug Development (2524)
Employer Resources (15)
FDA (431)
Job Trends (732)
News (9861)
Policy (845)
Tag
Academia (52)
Alliances (1243)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (16)
Approvals (420)
Artificial intelligence (7)
Bankruptcy (9)
Best Places to Work (600)
Cancer (94)
Cardiovascular disease (7)
Career advice (73)
CAR-T (28)
Cell therapy (46)
Clinical research (2071)
Collaboration (29)
COVID-19 (61)
C-suite (17)
Data (32)
Diagnostics (78)
Drug pricing (27)
Earnings (1707)
Employer branding (7)
Employer resources (12)
Events (1813)
Executive appointments (50)
FDA (447)
Funding (28)
Gene editing (6)
GLP-1 (36)
Government (131)
Healthcare (378)
Immunology and inflammation (7)
Infectious disease (63)
Interviews (19)
IPO (340)
IRA (22)
Job creations (150)
Job search strategy (63)
Layoffs (53)
Legal (224)
Liver cancer (8)
Lung cancer (15)
Lymphoma (7)
Medical device (77)
Medtech (77)
Mergers & acquisitions (583)
Metabolic disorders (8)
Neuropsychiatric disorders (7)
Neuroscience (67)
NextGen: Class of 2025 (235)
Non-profit (138)
Northern California (49)
Opinion (27)
People (2941)
Phase I (621)
Phase II (838)
Phase III (918)
Pipeline (36)
Podcasts (7)
Policy (27)
Postmarket research (123)
Preclinical (123)
Radiopharmaceuticals (21)
Rare diseases (16)
Real estate (127)
Regulatory (553)
Research institute (91)
Resumes & cover letters (10)
Schizophrenia (28)
Series A (7)
Series B (9)
Southern California (32)
Startups (163)
The Weekly (7)
United States (377)
Vaccines (18)
Venture capitalists (10)
Weight loss (7)
Date
Last 7 days (18)
Last 30 days (73)
Last 365 days (959)
2025 (125)
2024 (959)
2023 (958)
2022 (1740)
2021 (1679)
2020 (1462)
2019 (1093)
2018 (846)
2017 (905)
2016 (623)
2015 (808)
2014 (519)
2013 (474)
2012 (446)
2011 (483)
2010 (404)
Location
Africa (32)
Asia (942)
Australia (102)
California (95)
Canada (17)
China (8)
Connecticut (9)
Europe (2182)
Florida (42)
Illinois (8)
Maryland (7)
Massachusetts (82)
New Jersey (45)
New York (15)
North Carolina (17)
Northern California (49)
Pennsylvania (11)
South America (39)
Southern California (32)
Texas (15)
Virginia (14)
Washington State (11)
15,780 Results for "bristol myers squibb".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
February 14, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024
February 6, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase
December 12, 2024
·
1 min read
Biotech Bay
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb
Scenic Biotech announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.
April 30, 2024
·
2 min read
Job Trends
European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab
Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency (EMA) has validated the extension application to introduce a new route of administration (subcutaneous use) for Opdivo®.
June 21, 2024
·
45 min read
Business
Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected independent director Michael R. McMullen to the Board, effective July 1, 2024.
June 18, 2024
·
3 min read
Business
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Evotec SE announced that the Company has reached important scientific progress within its neuroscience collaboration with Bristol Myers Squibb triggering a research payment of US$ 20 m to Evotec.
June 12, 2024
·
4 min read
Deals
Bristol Myers Squibb Announces Dividend - June 18, 2024
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the $0.10 par value common stock of the company.
June 18, 2024
·
1 min read
Press Releases
Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma
February 10, 2025
·
18 min read
Biotech Bay
Bristol Myers Squibb to Participate in Upcoming Investor Conferences in May 2024
Bristol Myers Squibb announced that the company will participate in two upcoming investor conferences in May 2024.
May 7, 2024
·
1 min read
1 of 1,578
Next
